Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

Download

Total Articles

4
(from Reference Citation Analysis)

Article PDFs (0)

Cited by > 0 (1)

Searched Name

L. Terzi di Bergamo

Ranked By

Results Analysis

Year Published Analysis
Article Type Analysis
Publication Title Analysis
Category Analysis

Results Analysis

Indexed Articles

Year Published

Show more Refine

Article Type

Show more Refine

Article Statistics

Refine

MESH Headings

Show more Refine

First Author

Show more Refine

First Author Affiliations

Show more Refine

Authors

Show more Refine

Publication Titles

Show more Refine

Grant Agencies

Show more Refine

Countries/Regions

Show more Refine

Affiliations

Show more Refine

Corresponding Author Affiliations

Show more Refine

Category

Show more Refine

Number

Citation Analysis

Bonfiglio F, Bruscaggin A, Guidetti F, Terzi di Bergamo L, Faderl M, Spina V, Condoluci A, Bonomini L, Forestieri G, Koch R, Piffaretti D, Pini K, Pirosa MC, Cittone MG, Arribas A, Lucioni M, Ghilardi G, Wu W, Arcaini L, Baptista MJ, Bastidas G, Bea S, Boldorini R, Broccoli A, Canzonieri V, Cascione L, Ceriani L, Cogliatti S, Derenzini E, Devizzi L, Dietrich S, Elia AR, Facchetti F, Gaidano G, Garcia JF, Gerber B, Ghia P, Silva MG, Gritti G, Guidetti A, Hitz F, Inghirami G, Ladetto M, Lopez‐Guillermo A, Lucchini E, Maiorana A, Marasca R, Matutes E, Meignin V, Merli M, Moccia A, Mollejo M, Montalban C, Novak U, Oscier DG, Passamonti F, Piazza F, Pizzolitto S, Sabattini E, Salles G, Santambrogio E, Scarfó L, Stathis A, Stüssi G, Geyer JT, Tapia G, Thieblemont C, Tousseyn T, Tucci A, Visco C, Vitolo U, Zenz T, Zinzani PL, Khiabanian H, Calcinotto A, Bertoni F, Bhagat G, Campo E, Leval L, Dirnhofer S, Pileri SA, Piris MÁ, Traverse‐Glehen A, Tzankov A, Paulli M, Ponzoni M, Mazzucchelli L, Cavalli F, Zucca E, Rossi D. GENETIC AND PHENOTYPIC ATTRIBUTES OF SPLENIC MARGINAL ZONE LYMPHOMA. Hematol Oncol 2021. [DOI: 10.1002/hon.43_2879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]

Affiliation(s)

F. Bonfiglio Institute of Oncology Research Experimental Hematology Bellinzona Switzerland
A. Bruscaggin Institute of Oncology Research Experimental Hematology Bellinzona Switzerland
F. Guidetti Institute of Oncology Research Experimental Hematology Bellinzona Switzerland
L. Terzi di Bergamo Institute of Oncology Research Experimental Hematology Bellinzona Switzerland
M. Faderl Institute of Oncology Research Experimental Hematology Bellinzona Switzerland
V. Spina Institute of Oncology Research Experimental Hematology Bellinzona Switzerland
A. Condoluci Oncology Institute of Southern Switzerland Division of Hematology Bellinzona Switzerland
L. Bonomini International Extranodal Lymphoma Study Group IELSG Bellinzona Switzerland
G. Forestieri Institute of Oncology Research Experimental Hematology Bellinzona Switzerland
R. Koch Institute of Oncology Research Experimental Hematology Bellinzona Switzerland
D. Piffaretti Institute of Oncology Research Experimental Hematology Bellinzona Switzerland
K. Pini Institute of Oncology Research Experimental Hematology Bellinzona Switzerland
M. C. Pirosa Oncology Institute of Southern Switzerland Division of Hematology Bellinzona Switzerland
M. G. Cittone Oncology Institute of Southern Switzerland Division of Hematology Bellinzona Switzerland
A. Arribas Institute of Oncology Research Lymphoma Genomics Bellinzona Switzerland
M. Lucioni Fondazione IRCCS Policlinico San Matteo Unit of Anatomic Pathology Pavia Italy
G. Ghilardi Oncology Institute of Southern Switzerland Division of Hematology Bellinzona Switzerland
W. Wu Institute of Oncology Research Experimental Hematology Bellinzona Switzerland
L. Arcaini Fondazione IRCCS Policlinico San Matteo Division of Hematology Pavia Italy
M. J. Baptista Josep Carreras Leukaemia Research Institute Lymphoid neoplasms Group Badalona Spain
G. Bastidas Hospital Clínic i Provincial de Barcelona Division of Hematology Barcelona Spain
S. Bea Hospital Clínic Pathology Department Barcelona Spain
R. Boldorini University of Eastern Piedmont Division of Pathology Novara Italy
A. Broccoli IRCCS Azienda Ospedaliero‐Universitaria di Bologna Istituto di Ematologia Bologna Italy
V. Canzonieri CRO Aviano National Cancer Institute Pathology Unit Aviano Italy
L. Cascione Institute of Oncology Research Lymphoma Genomics Bellinzona Switzerland
L. Ceriani Imaging Institute of Southern Switzerland Clinic of Nuclear Medicine and PET‐CT centre Bellinzona Switzerland
S. Cogliatti Kantonsspital St. Gallen St.Gallen Institute of Pathology St.Gallen Switzerland
E. Derenzini IEO European Institute of Oncology IRCCS Onco‐hematology Div Milan Italy
L. Devizzi Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Division of Hematology Milan Italy
S. Dietrich University Hospital Heidelberg Division of Hematology Heidelberg Germany
A. R. Elia Institute of Oncology Research Cancer Immunotherapy Bellinzona Switzerland
F. Facchetti University of Brescia School of Medicine Department of Molecular and Translational Medicine Brescia Italy
G. Gaidano University of Eastern Piedmont Division of hematology Novara Italy
J. F. Garcia MD Anderson Cancer Center Division of Pathology Madrid Spain
B. Gerber Oncology Institute of Southern Switzerland Division of Hematology Bellinzona Switzerland
P. Ghia IRCCS Ospedale San Raffaele and Università Vita‐Salute San Raffaele Division of Hematology Milan Italy
M. G. Silva Instituto Português de Oncologia de Lisboa Division of Hematology Lisbon Portugal
G. Gritti Azienda Ospedaliera Papa Giovanni XXIII Division of Hematology Bergamo Italy
A. Guidetti Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Division of Hematology Milan Italy
F. Hitz Kantonsspital St. Gallen Division of Hematology St. Gallen Switzerland
G. Inghirami Weill Cornell Medical College Department of Pathology and Laboratory Medicine New York, New York USA
M. Ladetto Azienda Ospedaliera SS Antonio e Biagio Division of Hematology Alessandria Italy
A. Lopez‐Guillermo Hospital Clínic i Provincial de Barcelona Division of Lymphoid neoplasms Barcelona Spain
E. Lucchini Azienda Sanitaria Universitaria Giuliano Isontina Division of Hematology Trieste Italy
A. Maiorana Universitá degli Studi di Modena e Reggio Emilia Division of Pathology Modena Italy
R. Marasca University of Modena and Reggio Emilia Department of Medical and Surgical Sciences Modena Italy
E. Matutes Hospital Clínic i Provincial de Barcelona Haematopathology Unit Barcelona Spain
V. Meignin Saint Louis Hospital Division of Pathology Paris France
M. Merli University of Insubria and ASST Sette Laghi Ospedale di Circolo of Varese Division of Hematology Varese Italy
A. Moccia Oncology Institute of Southern Switzerland Clinic of Medical Oncology Bellinzona Switzerland
M. Mollejo Hospital Virgen de la Salud Division of Pathology Toledo Spain
C. Montalban MD Anderson Cancer Center Division of Hematology Madrid Spain
U. Novak University Cancer Center, Inselspital Department of Medical Oncology Bern Switzerland
D. G. Oscier Royal Bournemouth Hospital Division of Hematology Bournemouth UK
F. Passamonti University of Insubria and ASST Sette Laghi Ospedale di Circolo of Varese Department of Medicine and Surgery Varese Italy
F. Piazza Ospedale Universitario di Padova Division of Hematology Padova Italy
S. Pizzolitto Policlinico Universitario Division of Pathology Udine Italy
E. Sabattini S. Orsola‐Malpighi Hospital University of Bologna Department of Experimental Diagnostic and Specialty Medicine Bologna Italy
G. Salles Université de Lyon Faculté de Médecine et de Maïeutique Lyon Sud Lyon France
E. Santambrogio Candiolo Cancer Institute FPO‐IRCCS Division of Hematology Candiolo Italy
L. Scarfó IRCCS Ospedale San Raffaele and Università Vita‐Salute San Raffaele Division of Hematology Milan Italy
A. Stathis Oncology Institute of Southern Switzerland Clinic of Medical Oncology Bellinzona Switzerland
G. Stüssi Oncology Institute of Southern Switzerland Division of Hematology Bellinzona Switzerland
J. T. Geyer Weill Cornell Medical College Division of Anatomic Pathology and Clinical Pathology New York USA
G. Tapia Hospital Germans Trias I Pujol Division of Pathology Barcelona Spain
C. Thieblemont APHP, Hopital Saint‐Louis Hemato‐oncology unit Paris France
T. Tousseyn University Hospitals Leuven Department of Haematology Leuven Belgium
A. Tucci Spedali Civili Division of Hematology Brescia Italy
C. Visco University of Verona Department of Medicine Verona Italy
U. Vitolo Candiolo Cancer Institute FPO‐IRCCS Division of Hematology Candiolo Italy
T. Zenz University Hospital Zurich Department of Medical Oncology and Hematology Zurich Switzerland
P. L. Zinzani Università di Bologna Dipartimento di Medicina Specialistica Diagnostica e Sperimentale Bologna Italy
H. Khiabanian Rutgers University Center for Systems and Computational Biology New Brunswick USA
A. Calcinotto Institute of Oncology Research Cancer Immunotherapy Bellinzona Switzerland
F. Bertoni Institute of Oncology Research Lymphoma Genomics Bellinzona Switzerland
G. Bhagat Columbia University Department of Pathology and Cell Biology New York USA
E. Campo Hospital Clínic Pathology Department Barcelona Spain
L. Leval Institut universitaire de pathologie Division of Pathology Lausanne Switzerland
S. Dirnhofer University Hospital Basel Institute of Pathology and Medical Genetics Basel Switzerland
S. A. Pileri European Institute of Oncology IRCCS Haematopathology Division Milan Italy
M. Án. Piris Fundación Jiménez Díaz, Pathology Service Madrid Spain
A. Traverse‐Glehen Centre Hospitalier Lyon Sud Division of Pathology Lyon France
A. Tzankov University Hospital Basel Institute of Pathology and Medical Genetics Basel Switzerland
M. Paulli Fondazione IRCCS Policlinico San Matteo Unit of Anatomic Pathology Pavia Italy
M. Ponzoni San Raffaele Scientific Institute Ateneo Vita‐Salute San Raffaele University and Pathology Unit Milan Italy
L. Mazzucchelli Cantonal Institute of Pathology Pathology unit Locarno Switzerland
F. Cavalli Institute of Oncology Research Bellinzona Switzerland
E. Zucca Oncology Institute of Southern Switzerland Clinic of Medical Oncology Bellinzona Switzerland
D. Rossi Institute of Oncology Research Experimental Hematology Bellinzona Switzerland

Collapse

Terzi di Bergamo L, Forestieri G, Loh JW, Singh A, Spina V, Zucchetto A, Condoluci A, Faderl M, Koch R, Bruscaggin A, Pini K, Wu W, Piffaretti D, Bittolo T, Tissino E, Paoli L, Deambrogi C, Frustaci AM, Autore F, Merli M, Scarfò L, Rasi S, Passweg J, Moia R, Martines C, Ghia P, Cavalli F, Zucca E, Gerber B, Gillessen S, Stüssi G, Montillo M, Passamonti F, Gregor M, Laurenti L, Tedeschi A, Gaidano G, Efremov D, Gattei V, Khiabanian H, Rossi D. ADAPTATION OF CHRONIC LYMPHOCYTIC LEUKEMIA TO IBRUTINIB IS MEDIATED BY EPIGENETIC PLASTICITY OF RESIDUAL DISEASE AND BY‐PASS SIGNALING VIA MAPK PATHWAY. Hematol Oncol 2021. [DOI: 10.1002/hon.29_2879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]

Affiliation(s)

L Terzi di Bergamo Institute of Oncology Research Laboratory of Experimental Hematology Bellinzona Switzerland
G Forestieri Institute of Oncology Research Laboratory of Experimental Hematology Bellinzona Switzerland
J. W Loh Rutgers Cancer Institute of New Jersey Center for Systems and Computational Biology New Brunswick New Jersey USA
A Singh Rutgers Cancer Institute of New Jersey Center for Systems and Computational Biology New Brunswick New Jersey USA
V Spina Institute of Oncology Research Laboratory of Experimental Hematology Bellinzona Switzerland
A Zucchetto Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Clinical and Experimental Onco‐Hematology Unit Aviano Italy
A Condoluci Oncology Institute of Southern Switzerland Clinic of Hematology Bellinzona Switzerland
M Faderl Institute of Oncology Research Laboratory of Experimental Hematology Bellinzona Switzerland
R Koch Institute of Oncology Research Laboratory of Experimental Hematology Bellinzona Switzerland
A Bruscaggin Institute of Oncology Research Laboratory of Experimental Hematology Bellinzona Switzerland
K Pini Institute of Oncology Research Laboratory of Experimental Hematology Bellinzona Switzerland
W Wu Institute of Oncology Research Laboratory of Experimental Hematology Bellinzona Switzerland
D Piffaretti Institute of Oncology Research Laboratory of Experimental Hematology Bellinzona Switzerland
T Bittolo Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Clinical and Experimental Onco‐Hematology Unit Aviano Italy
E Tissino Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Clinical and Experimental Onco‐Hematology Unit Aviano Italy
L Paoli University of Eastern Piedmont Division of Hematology Department of Translational Medicine Novara Italy
C Deambrogi University of Eastern Piedmont Division of Hematology Department of Translational Medicine Novara Italy
A. M Frustaci ASST Grande Ospedale Metropolitano Niguarda Niguarda Cancer Center Department of Hematology Milan Italy
F Autore Catholic University of the Sacred Hearth Fondazione Policlinico Universitario A. Gemelli Hematology Institute Rome Italy
M Merli Ospedale di Circolo e Fondazione Macchi University of Insubria Division of Hematology Varese Italy
L Scarfò IRCCS San Raffaele Scientific Institute and Vita‐Salute San Raffaele University Strategic Research Program on CLL Division of Experimental Oncology Milan Italy
S Rasi University of Eastern Piedmont Division of Hematology Department of Translational Medicine Novara Italy
J Passweg University Hospital Basel Department of Haematology Basel Switzerland
R Moia University of Eastern Piedmont Division of Hematology Department of Translational Medicine Novara Italy
C Martines International Centre for Genetic Engineering and Biotechnology Molecular Hematology Trieste Italy
P Ghia IRCCS San Raffaele Scientific Institute and Vita‐Salute San Raffaele University Strategic Research Program on CLL Division of Experimental Oncology Milan Italy
F Cavalli Università della Svizzera Italiana Institute of Oncology Research Bellinzona Switzerland
E Zucca Oncology Institute of Southern Switzerland Clinic of Oncology Bellinzona Switzerland
B Gerber Oncology Institute of Southern Switzerland Clinic of Hematology Bellinzona Switzerland
S Gillessen Oncology Institute of Southern Switzerland Clinic of Oncology Bellinzona Switzerland
G Stüssi Oncology Institute of Southern Switzerland Clinic of Hematology Bellinzona Switzerland
M Montillo ASST Grande Ospedale Metropolitano Niguarda Niguarda Cancer Center Department of Hematology Milan Italy
F Passamonti Ospedale di Circolo e Fondazione Macchi University of Insubria Division of Hematology Varese Italy
M Gregor Cantonal Hospital Lucerne Division of Haematology and Central Haematology Laboratory Lucerne Switzerland
L Laurenti Catholic University of the Sacred Hearth Fondazione Policlinico Universitario A. Gemelli Hematology Institute Rome Italy
A Tedeschi ASST Grande Ospedale Metropolitano Niguarda Niguarda Cancer Center Department of Hematology Milan Italy
G Gaidano University of Eastern Piedmont Division of Hematology Department of Translational Medicine Novara Italy
D Efremov International Centre for Genetic Engineering and Biotechnology Molecular Hematology Trieste Italy
V Gattei Centro di Riferimento Oncologico di Aviano (CRO) IRCCS, Clinical and Experimental Onco‐Hematology Unit Aviano Italy
H Khiabanian Rutgers Cancer Institute of New Jersey Center for Systems and Computational Biology New Brunswick New Jersey USA
D Rossi Institute of Oncology Research Experimental Hematology Bellinzona Switzerland

Collapse

Spina V, Pirosa MC, Bruscaggin A, Condoluci A, Pini K, Forestieri G, Zangrilli I, di Trani M, Kurlapski M, Moccia A, Moia R, Bulian P, Annunziata S, Borsatti E, Rodari M, Romanowicz G, Sacchetti GM, Faderl M, Koch R, Piffaretti D, Terzi di Bergamo L, Stasia A, Cittone M, Chauvie S, Stüssi G, Gerber B, Stathis A, Sommer SG, Cavalli F, Zucca E, Gattei V, Zaucha JM, Pinto A, Gaidano G, Carlo‐Stella C, Hohaus S, Ceriani L, Rossi D. CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER IN CLASSIC HODGKIN LYMPHOMA. Hematol Oncol 2021. [DOI: 10.1002/hon.70_2879] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]

Affiliation(s)

V. Spina Institute of Oncology Research Division of Experimental Hematology Bellinzona Switzerland
M. C. Pirosa Oncology Institute of Southern Switzerland Division of Hematology Bellinzona Switzerland
A. Bruscaggin Institute of Oncology Research Division of Experimental Hematology Bellinzona Switzerland
A. Condoluci Institute of Oncology Research Division of Experimental Hematology Bellinzona Switzerland
K. Pini Institute of Oncology Research Division of Experimental Hematology Bellinzona Switzerland
G. Forestieri Institute of Oncology Research Division of Experimental Hematology Bellinzona Switzerland
I. Zangrilli Fondazione Policlinico Universitario Agostino Gemelli IRCCS Department of diagnostic imaging, oncological radiotherapy and hematology Rome Italy
M. di Trani Humanitas Clinical and Research Center Humanitas Cancer Center Milan Italy
M. Kurlapski Medical University of Gdańsk Department of Hematology and Transplantology Gdańsk Poland
A. Moccia Oncology Institute of Southern Switzerland Clinic of Medical Oncology Bellinzona Switzerland
R. Moia University of Eastern Piedmont Division of hematology Novara Italy
P. Bulian Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Clinical and Experimental Onco‐Hematology Unit Aviano Italy
S. Annunziata Università Cattolica del Sacro Cuore Institute of Nuclear Medicine Rome Italy
E. Borsatti IRCCS CRO, Nuclear Medicine Aviano Italy
M. Rodari Humanitas Clinical and Research Center IRCCS Unit of Nuclear Medicine Milan Italy
G. Romanowicz Medical University of Gdansk Department of Nuclear Medicine Gdansk Poland
G. M. Sacchetti “Maggiore della Carità” Hospital Nuclear Medicine Novara Italy
M. Faderl Institute of Oncology Research Division of Experimental Hematology Bellinzona Switzerland
R. Koch Institute of Oncology Research Division of Experimental Hematology Bellinzona Switzerland
D. Piffaretti Institute of Oncology Research Division of Experimental Hematology Bellinzona Switzerland
L. Terzi di Bergamo Institute of Oncology Research Division of Experimental Hematology Bellinzona Switzerland
A. Stasia Oncology Institute of Southern Switzerland Division of Hematology Bellinzona Switzerland
M. Cittone Oncology Institute of Southern Switzerland Division of Hematology Bellinzona Switzerland
S. Chauvie Santa Croce e Carle Hospital Department of Medical Physics Cuneo Italy
G. Stüssi Oncology Institute of Southern Switzerland Division of Hematology Bellinzona Switzerland
B. Gerber Oncology Institute of Southern Switzerland Division of Hematology Bellinzona Switzerland
A. Stathis Oncology Institute of Southern Switzerland Clinic of Medical Oncology Bellinzona Switzerland
S. Gillessen Sommer Oncology Institute of Southern Switzerland Clinic of Medical Oncology Bellinzona Switzerland
F. Cavalli Institute of Oncology Research Division of Experimental Hematology Bellinzona Switzerland
E. Zucca Oncology Institute of Southern Switzerland Clinic of Medical Oncology Bellinzona Switzerland
V. Gattei Centro di Riferimento Oncologico di Aviano (CRO) IRCCS Clinical and Experimental Onco‐Hematology Unit Aviano Italy
J. M. Zaucha Medical University of Gdańsk Department of Hematology and Transplantology Gdańsk Poland
A. Pinto National Cancer Institute Fondazione “G. Pascale” IRCCS Hematology‐Oncology and Stem Cell transplantation Unit Naples Italy
G. Gaidano University of Eastern Piedmont Division of hematology Novara Italy
C. Carlo‐Stella Humanitas Clinical and Research Center Humanitas Cancer Center Milan Italy
S. Hohaus Fondazione Policlinico Universitario Agostino Gemelli IRCCS Department of diagnostic imaging, oncological radiotherapy and hematology Rome Italy
L. Ceriani Imaging Institute of Southern Switzerland Clinic of Nuclear Medicine and Molecular Imaging Bellinzona Switzerland
D. Rossi Institute of Oncology Research Division of Experimental Hematology Bellinzona Switzerland

Collapse

Condoluci A, Terzi di Bergamo L, Langerbeins P, Hoechstetter M, Herling C, De Paoli L, Delgado J, Gentile M, Doubek M, Mauro F, Chiodin G, Mattsson M, Bahlo J, Cutrona G, Kotaskova J, Deambrogi C, Moia R, Gerber B, Zucca E, Ghielmini M, Cavalli F, Stüssi G, Neri A, Ferrarini M, Rosenquist R, Forconi F, Foà R, Pospisilova S, Morabito F, Wierda W, Montserrat E, Gaidano G, Hallek M, Rossi D. INTERNATIONAL PROGNOSTIC SCORE FOR EARLY STAGE CHRONIC LYMPHOCYTIC LEUKEMIA (IPS-A). Hematol Oncol 2019. [DOI: 10.1002/hon.51_2629] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]

Affiliation(s)

A. Condoluci Experimental Hematology; Institute of Oncology Research; Oncology Institute of Southern Switzerland; Bellinzona Switzerland
L. Terzi di Bergamo Experimental Hematology; Institute of Oncology Research; Bellinzona Switzerland
P. Langerbeins University of Cologne; Center of Integrated Oncology Cologne-Bonn, German CLL Study Group; Köln Germany
M. Hoechstetter University of Cologne; Center of Integrated Oncology Cologne-Bonn, German CLL Study Group; Köln Germany
C. Herling University of Cologne; Center of Integrated Oncology Cologne-Bonn, German CLL Study Group; Köln Germany
L. De Paoli Translational Medicine; University of Eastern Piedmont; Novara Italy
J. Delgado Hematology; Hospital Clínic de Barcelona; Barcelona Spain
M. Gentile Hematology; Azienda Ospedaliera (AO) of Cosenza; Cosenza Italy
M. Doubek Hematology and Oncology; University Hospital of Brno; Brno Czech Republic
F.R. Mauro Hematology; Sapienza University; Rome Italy
G. Chiodin Hematology; Southampton University; Southampton United Kingdom
M. Mattsson Immunology; Genetics and Pathology, Uppsala University; Uppsala Sweden
J. Bahlo University of Cologne; Center of Integrated Oncology Cologne-Bonn, German CLL Study Group; Köln Germany
G. Cutrona Hematology; IRCCS Ospedale Policlinico San Martino; Genoa Italy
J. Kotaskova Hematology and Oncology; University Hospital of Brno; Brno Czech Republic
C. Deambrogi Translational Medicine; University of Eastern Piedmont; Novara Italy
R. Moia Translational Medicine; University of Eastern Piedmont; Novara Italy
B. Gerber Onco-hematology; Oncology Institute of Southern Switzerland; Bellinzona Switzerland
E. Zucca Onco-hematology; Oncology Institute of Southern Switzerland; Bellinzona Switzerland
M. Ghielmini Onco-hematology; Oncology Institute of Southern Switzerland; Bellinzona Switzerland
F. Cavalli Onco-hematology; Oncology Institute of Southern Switzerland; Bellinzona Switzerland
G. Stüssi Onco-hematology; Oncology Institute of Southern Switzerland; Bellinzona Switzerland
A. Neri Hematology; University of Milan; Milan Italy
M. Ferrarini Hematology; University of Genoa; Genoa Italy
R. Rosenquist Immunology; Genetics and Pathology, Uppsala University; Uppsala Sweden
F. Forconi Hematology; Southampton University; Southampton United Kingdom
R. Foà Hematology; Sapienza University; Rome Italy
S. Pospisilova Hematology and Oncology; University Hospital of Brno; Brno Czech Republic
F. Morabito Hematology; Augusta Victoria Hospital; Jerusalem Israel
W.G. Wierda MD Anderson Cancer Center; University of Texas; Houston United States
E. Montserrat Hematology; Hospital Clínic de Barcelona; Barcelona Spain
G. Gaidano Translational Medicine; University of Eastern Piedmont; Novara Italy
M. Hallek University of Cologne; Center of Integrated Oncology Cologne-Bonn, German CLL Study Group; Köln Germany
D. Rossi Experimental Hematology; Institute of Oncology Research; Oncology Institute of Southern Switzerland; Bellinzona Switzerland

Collapse